Skip to main content
OpenTrials

Clinical trial condition

Stargardt Disease

Explore clinical trials studying Stargardt Disease. Study availability and eligibility vary by location and protocol.

56 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Stargardt Disease trial results

Active, Not Recruiting

A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease

NCT06388083

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more
Locations
  • Belite Study Site - US08 Phoenix, Arizona, United States
  • Belite Study Site - US05 La Jolla, California, United States
  • Belite Study Site - US09 San Francisco, California, United States
  • Belite Study Site - US06 Miami, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

NCT04239625

Conditions
Autosomal Recessive Stargardt Disease 1 (ABCA4-related), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Los Angeles, California, United States
  • Alkeus Site Aurora, Colorado, United States
  • Alkeus Site Gainesville, Florida, United States
View Trial Details

Related conditions